PRECISION BIOSCIENCES INC Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRECISION BIOSCIENCES INC stock issued during period, value, new issues for the quarter ending 2024-06-30 was $300.00K, a 84.05% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, new issues for the quarter ending 2023-09-30 was -$108.00K.
- PRECISION BIOSCIENCES INC stock issued during period, value, new issues for the quarter ending 2023-06-30 was $1.88M, a 96.05% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, new issues for the quarter ending 2023-03-31 was $416.00K, a 74.74% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, new issues for fiscal 2025 was $259.00K, a 13.67% decline from fiscal 2024.
- PRECISION BIOSCIENCES INC stock issued during period, value, new issues for fiscal 2024 was $300.00K, a 94.35% decline from fiscal 2023.
- PRECISION BIOSCIENCES INC stock issued during period, value, new issues for fiscal 2023 was $5.31M, a 89.24% decline from fiscal 2022.
- PRECISION BIOSCIENCES INC stock issued during period, value, new issues for fiscal 2022 was $49.32M, a 93.36% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $259.00K 10-K · filed 2026-03-12 | |
| 2024-12-31 | $300.00K 10-K · filed 2026-03-12 | |
| 2024-06-30 | $300.00K 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $5.31M 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$108.00K 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $1.88M 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $416.00K 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $49.32M 10-K · filed 2024-03-27 | |
| 2022-06-30 | $47.67M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $1.65M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $25.50M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $3.84M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $14.83M 10-Q · filed 2022-11-08 | |
| 2018-12-31 | $109.74M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $21.92M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $87.83M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |